未登录 IRON-DRIVEN MESENCHYMAL TRANSITION ENHANCES INVASION IN GLIOBLASTOMA 铁驱动间充质转化增强胶质母细胞瘤的侵袭性 Petry, C.; Buchholz, O.; Mohammed, A. O.; Al Shhab, M.; Vasilikos, I; Shah, M.; Grauvogel, J.; Roelz, R.; Vlachos, A.; Beck, J.; Hofmann, U. G.; Joseph, K.; Ravi, V. M. 分享 收藏
Elective endovascular reperfusion therapies in intermediate-high risk pulmonary embolism after PERT assesment Cigalini, I; Najenson, M.; Petry, C.; Cardona, M.; Balparda, H.; Montiel, F.; Montenegro, M.; Cabral, L.; Fedele, J.; Gumpel, C.; Depaoli, C.; Polillo, D.; Zarria, L.; Cigalini, C.; Dumont, C. 分享 收藏
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy EndoPredict和EPclin与Oncotype DX复发评分预测内分泌治疗后远处复发风险的比较 Buus, Richard; Sestak, Ivana; Kronenwett, Ralf; Denkert, Carsten; Dubsky, Peter; Krappmann, Kristin; Scheer, Marsel; Petry, Christoph; Cuzick, Jack; Dowsett, Mitch 分享 收藏
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study Martin, Miguel; Brase, Jan C.; Ruiz, Amparo; Prat, Aleix; Kronenwett, Ralf; Calvo, Lourdes; Petry, Christoph; Bernard, Philip S.; Ruiz-Borrego, Manuel; Weber, Karsten E.; Rodriguez, Cesar A.; Alvarez, Isabel M.; Segui, Miguel A.; Perou, Charles M.; Casas, Maribel; Carrasco, Eva; Caballero, Rosalia; Rodriguez-Lescure, Alvaro 分享 收藏
EndoPredict (EPclin) score for estimating residual distant recurrence (DR) risk in ER+/HER2-breast cancer (br ca) patients treated with 5 years adjuvant endocrine therapy alone: Validation and comparison with the oncotype DX recurrence score (RS) Dowsett, M.; Sestak, I.; Buus, R.; Kronenwett, R.; Denkert, C.; Krappmann, K.; Scheer, M.; Petry, C.; Dubsky, P.; Cuzick, J. 分享 收藏
EndoPredict-based treatment decision can reduce chemotherapy usage in ER+, HER2-breast cancer Schlake, G.; Kronenwett, R.; Tiecke, F.; Kastrup, K.; Bleuel, N.; Petry, C.; Wilhelms, S.; Toennies, P.; Schlake, W. 分享 收藏
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM 9906 trial Martin, Miguel; Brase, Jan C.; Calvo, Lourdes; Krappmann, Kristin; Ruiz-Borrego, Manuel; Fisch, Karin; Ruiz, Amparo; Weber, Karsten E.; Munarriz, Blanca; Petry, Christoph; Rodriguez, Cesar A.; Kronenwett, Ralf; Crespo, Carmen; Alba, Emilio; Carrasco, Eva; Casas, Maribel; Caballero, Rosalia; Rodriguez-Lescure, Alvaro 分享 收藏
Comparison of PAM50 risk of recurrence (ROR) scores with EndoPredict for predicting risk of distant metastasis in ER+/HER2-, early node-positive breast cancer patients treated with adjuvant chemotherapy - A GEICAM/ 9906 sub-study Martin, M.; Brase, J. C.; Perou, C. M.; Ruiz, A.; Prat, A.; Weber, K. E.; Calvo, L.; Petry, C.; Bernard, P. S.; Ruiz-Borrego, M.; Kronenwett, R.; Santaballa, A. M.; Rodriguez, C. A.; Alvarez, I. M.; Segui, M. A.; Casas, M.; Carrasco, E.; Caballero, R.; Rodriguez-Lescure, A. 分享 收藏
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer Dubsky, P.; Filipits, M.; Jakesz, R.; Rudas, M.; Singer, C. F.; Greil, R.; Dietze, O.; Luisser, I.; Klug, E.; Sedivy, R.; Bachner, M.; Mayr, D.; Schmidt, M.; Gehrmann, M. C.; Petry, C.; Weber, K. E.; Kronenwett, R.; Brase, J. C.; Gnant, M. 分享 收藏
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy Denkert, C.; Loibl, S.; Kronenwett, R.; Budczies, J.; von Toerne, C.; Nekljudova, V.; Darb-Esfahani, S.; Solbach, C.; Sinn, B. V.; Petry, C.; Mueller, B. M.; Hilfrich, J.; Altmann, G.; Staebler, A.; Roth, C.; Ataseven, B.; Kirchner, T.; Dietel, M.; Untch, M.; von Minckwitz, G. 分享 收藏
Prognostic performance of the EndoPredict score in node-positive chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM/9906 trial. Martin, M.; Brase, J. C.; Ruiz-Borrego, M.; Krappmann, K.; Munarriz, B.; Fisch, K.; Ruiz, A.; Weber, K. E.; Crespo, C.; Petry, C.; Rodriguez, C. A.; Kronenwett, R.; Calvo, L.; Alba, E.; Carrasco, E.; Casas, M.; Caballero, R.; Rodriguez-Lescure, A. 分享 收藏
The EndoPredict score identifies late distant metastases in ER+/HER2-breast cancer patients Dubsky, P.; Brase, J. C.; Fisch, K.; Jakesz, R.; Singer, C. F.; Greil, R.; Dietze, O.; Weber, K. E.; Petry, C.; Kronenwett, R.; Rudas, M.; Knauer, M.; Gnant, M.; Filipits, M. 分享 收藏
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test 分散基因表达分析: Endopredict基因组多分析物乳腺癌预后测试的分析验证 Kronenwett, Ralf; Bohmann, Kerstin; Prinzler, Judith; Sinn, Bruno V.; Haufe, Franziska; Roth, Claudia; Averdick, Manuela; Ropers, Tanja; Windbergs, Claudia; Brase, Jan C.; Weber, Karsten E.; Fisch, Karin; Mueller, Berit M.; Schmidt, Marcus; Filipits, Martin; Dubsky, Peter; Petry, Christoph; Dietel, Manfred; Denkert, Carsten 分享 收藏
Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy Dolores Giraldez, Maria; Jose Lozano, Juan; Cuatrecasas, Miriam; Alonso-Espinaco, Virginia; Maurel, Joan; Marmol, Maribel; Hoerndler, Carlos; Ortego, Javier; Alonso, Vicente; Escudero, Pilar; Ramirez, Gina; Petry, Christoph; LaSalvia, Luis; Bohmann, Kerstin; Wirtz, Ralph; Mira, Aurea; Castells, Antoni 分享 收藏
Decentral gene expression analysis for ER+/Her2-breast cancer: results of a proficiency testing program for the EndoPredict assay Denkert, Carsten; Kronenwett, Ralf; Schlake, Werner; Bohmann, Kerstin; Penzel, Roland; Weber, Karsten E.; Hoefler, Heinz; Lehmann, Ulrich; Schirmacher, Peter; Specht, Katja; Rudas, Margaretha; Kreipe, Hans-Heinrich; Schraml, Peter; Schlake, Gudrun; Bago-Horvath, Zsuzsanna; Tiecke, Frank; Varga, Zsuzsanna; Moch, Holger; Schmidt, Marcus; Prinzler, Judith; Kerjaschki, Dontscho; Sinn, Bruno Valentin; Mueller, Berit Maria; Filipits, Martin; Petry, Christoph; Dietel, Manfred 分享 收藏
The EndoPredict Score Is a Response Predictor for Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer. Brase, J. C.; Gehrmann, M. C.; Petry, C.; Weber, K. E.; Schmidt, M.; Koelbl, H.; Brauch, H.; Schwab, M.; Mueller, V.; Jaenicke, F.; Rody, A.; Kaufmann, M.; Filipits, M.; Gnant, M.; Denkert, C.; Loibl, S.; von Minckwitz, G.; Kronenwett, R. 分享 收藏
分享 收藏